Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study.
Masashi IkedaJun IshigookaIchiro NaoiMasahiro MatsumotoYuichi KanamoriHiroshi NakamuraTeruhiko HiguchiPublished in: CNS drugs (2021)
NCT02335658.